NCT07060482View on ClinicalTrials.gov

Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study

Not yet recruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2026

Conditions
Gastric Atrophy
Interventions
DIAGNOSTIC_TEST

Panel of biomarkers including Gastrin 17, pepsinogen 1 and 2, and anti-helicobacter pylori antibodies.

This study will be assessing the diagnostic accuracy of this panel of biomarkers for diagnosing gastric atrophy in the Irish population for the first time. This reflects the assessment of these biomarkers in diagnosing gastric atrophy in a low-risk Western population.

All Listed Sponsors
lead

Royal College of Surgeons, Ireland

OTHER